Personalized dosing is a medical necessity, allowing clinicians to help reduce risks, improve outcomes, and free patients from bias, stigma, and the physical toll obesity takes
Some common interactions include SSRIs with blood thinners, benzodiazepines with opioid pain medications, and various anxiety medications with certain antibiotics
The growing interest in these peptides is supported by peer-reviewed research from respected journals
Successful application of various GLP-1 mimetics to treat type 2 diabetes mellitus (T2DM) and obesity highlights the clinical value of this group of drug targets 3
If covered, you might have a similar copay
We celebrate the dedication of researchers, healthcare professionals, and participants who make these advancements possible